"We are pleased the FDA has accepted our NDA for Bumetanide Nasal Spray," said Benjamin Esque, CEO of Corstasis Therapeutics ...

The U.S. Food and Drug Administration has approved a nose spray to help treat depression, Johnson & Johnson announced Tuesday ...

The Central Intelligence Agency with a "low confidence" has changed its stance and concluded that it's likely the COVI-19 ...

A group of Estonian psychiatrists and civic activists believe that allowing the therapeutic use of currently prohibited ...

Robbins LLP informs investors that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired ESSA Pharma Inc. securities between December 12, 2023 and October ...

Tripadvisor®, the world's largest travel platform, today announced the launch of its first ever Trendcast report, exploring the trends reshaping travel and predictions for the years ...

Rather than further criminalizing substance use disorder, we must legitimize trauma-informed care as a key pathway to ending ...